Major developments span mental health treatment concerns, HIV prevention strategies, diabetes complications management, and digital healthcare accessibility challenges.

Australia faces growing scrutiny over involuntary electroconvulsive therapy (ECT) use for severe mental illness, with experts divided on whether benefits justify ethical concerns about informed consent and patient autonomy.

A new clinical trial on low-dose lithium for cognitive preservation failed to provide definitive answers, leaving uncertainty about lithium's potential role in protecting brain function in aging populations.

England's general practitioners are identified as critical to achieving HIV elimination by 2030, as the country approaches national targets but still needs to reach undiagnosed populations through primary care.

Older patients in the UK are increasingly unable to access digital NHS services for booking GP appointments due to lacking technical skills, devices, or adequate support, risking healthcare exclusion.

Seven British passengers evacuated from the hantavirus-affected cruise ship MV Hondius mid-voyage, with two now self-isolating in the UK as authorities monitor for potential virus transmission.

Metabolic bariatric surgery carries significantly higher risks for multiple micronutrient deficiencies and metabolic complications compared to GLP-1 receptor agonist therapy for weight management.

Three therapeutic strategies—SGLT2 inhibitors, finerenone, and GLP-1/GIP agents—show promise in slowing kidney disease progression and reducing cardiovascular risk in type 1 diabetes patients.

The monoclonal antibody obinutuzumab demonstrates effectiveness in reducing chronic graft-versus-host disease (GVHD) complications following stem cell transplantation in randomized clinical trials.